Celltrion Pharm, Inc. (KOSDAQ:068760)
49,000
-900 (-1.80%)
Jun 27, 2025, 3:30 PM KST
Celltrion Pharm Market Cap
Celltrion Pharm has a market cap or net worth of 2.16 trillion as of June 27, 2025. Its market cap has decreased by -44.64% in one year.
Market Cap
2.16T
Enterprise Value
n/a
Revenue
274.73B
Ranking
n/a
PE Ratio
83.36
Stock Price
49,000.00
Market Cap Chart
Since February 3, 2006, Celltrion Pharm's market cap has increased from 66.37B to 2.16T, an increase of 3,150.39%. That is a compound annual growth rate of 19.67%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jun 18, 2025 | 2,157.33B | -12.53% |
Dec 30, 2024 | 2,466.43B | -35.41% |
Dec 28, 2023 | 3,818.49B | 44.48% |
Dec 29, 2022 | 2,642.93B | -43.45% |
Dec 30, 2021 | 4,673.68B | -46.31% |
Dec 30, 2020 | 8,705.45B | 511.51% |
Dec 30, 2019 | Pro | Pro |
Dec 28, 2018 | Pro | Pro |
Dec 28, 2017 | Pro | Pro |
Dec 29, 2016 | Pro | Pro |
Dec 30, 2015 | Pro | Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Samsung Biologics | 71.10T |
Celltrion | 35.38T |
ALTEOGEN | 20.57T |
Yuhan | 7,588.59B |
SK Biopharmaceuticals | 7,196.99B |
HLB Co., Ltd. | 6,283.13B |
PharmaResearch | 5,189.63B |
Peptron | 4,822.55B |